HHS announces standard definition for opioid withdrawal in infants

Feb 01, 2022 - 11:58 AM
HHS Logo web sized 900x400

The Department of Health and Human Services yesterday announced a standard clinical definition for opioid withdrawal in infants. Recently published in the Journal of Pediatrics, the definition includes prenatal exposure and at least two of the most common clinical signs of withdrawal (excessive crying, fragmented sleep, tremors, increased muscle tone or gastrointestinal dysfunction). 

“As a pediatrician, I have seen the need for a standard clinical definition for opioid withdrawal in neonates, and am excited to see this step in improving care for infants and their families as part of the HHS Overdose Prevention Strategy,” said HHS Assistant Secretary for Health ADM Rachel Levine. “I look forward to working across all health sectors to get this definition adopted into clinical practice.”
 

Related News Articles

Headline
FDA issues guidance to expand non-opioid treatments for chronic pain
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
Study finds less than 40% of Medicare beneficiaries with OUD receive standard care
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
FDA announces labeling changes to opioid pain medications 
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…
Headline
Overdose deaths dropped an estimated 27% in 2024
Overdose deaths in the U.S. fell 26.9% last year to 80,391, according to estimates from the Centers for Disease Control and Prevention. The agency reported…
Headline
FDA approves first-in-class non-opioid painkiller 
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
AHA podcast: Englewood Health's Strategies to Combat Rising Opioid Use in Post-Pandemic America
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…